CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 414 filers reported holding CRISPR THERAPEUTICS AG in Q4 2020. The put-call ratio across all filers is 1.10 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $763,006 | +65.5% | 16,810 | +104.7% | 0.02% | +110.0% |
| Q2 2023 | $461,077 | +59.0% | 8,213 | +28.1% | 0.01% | +25.0% |
| Q1 2023 | $290,015 | +7.5% | 6,412 | -3.4% | 0.01% | 0.0% |
| Q4 2022 | $269,875 | -48.8% | 6,639 | -17.6% | 0.01% | -50.0% |
| Q3 2022 | $527,000 | +2.1% | 8,053 | -5.1% | 0.02% | -27.3% |
| Q2 2022 | $516,000 | +11.9% | 8,484 | +15.8% | 0.02% | +46.7% |
| Q1 2022 | $461,000 | -13.8% | 7,329 | +3.9% | 0.02% | 0.0% |
| Q4 2021 | $535,000 | -51.5% | 7,054 | -28.4% | 0.02% | -57.1% |
| Q3 2021 | $1,103,000 | +6.2% | 9,849 | +53.5% | 0.04% | +2.9% |
| Q2 2021 | $1,039,000 | +71.7% | 6,416 | +29.4% | 0.03% | +61.9% |
| Q1 2021 | $605,000 | -5.9% | 4,960 | +18.1% | 0.02% | -38.2% |
| Q4 2020 | $643,000 | +70.1% | 4,199 | -7.0% | 0.03% | +70.0% |
| Q3 2020 | $378,000 | +17.0% | 4,516 | +2.9% | 0.02% | -9.1% |
| Q2 2020 | $323,000 | +60.7% | 4,387 | -7.1% | 0.02% | +29.4% |
| Q1 2020 | $201,000 | -30.0% | 4,723 | +0.4% | 0.02% | -29.2% |
| Q4 2019 | $287,000 | -20.7% | 4,704 | -38.7% | 0.02% | -40.0% |
| Q2 2019 | $362,000 | – | 7,679 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $27,989,046 | 33.20% |
| Gilfoyle Management LLC | 100 | $4,842 | 15.90% |
| NEA Management Company, LLC | 1,587,854 | $89,142,124 | 6.80% |
| ARK Investment Management | 7,338,447 | $411,980,394 | 2.73% |
| Nikko Asset Management Americas, Inc. | 3,533,357 | $198,327,328 | 2.09% |
| Del-Sette Capital Management, LLC | 33,661 | $1,889,729 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Merlin Capital, Inc | 8,802 | $494,144 | 1.67% |
| Green Alpha Advisors, LLC | 34,373 | $1,929,700 | 1.27% |